Literature DB >> 19178387

A comparative study of cardiac dysautonomia in autosomal dominant spinocerebellar ataxias and idiopathic sporadic ataxias.

M Netravathi1, T N Sathyaprabha, K Jayalaxmi, P Datta, M Nirmala, P K Pal.   

Abstract

OBJECTIVES: Comparative evaluation of cardiac dysautonomia in spinocerebellar ataxias (SCA) and idiopathic sporadic ataxias (IA) not fulfilling the criteria of multiple system atrophy.
MATERIAL AND METHODS: Cardiac autonomic functions were evaluated in 14 SCA (SCA1 = 6, SCA2 = 5 and SCA3 = 3) and 10 IA patients, comparable for age, age at onset, duration and severity of illness. The results were categorized as early, definitive, or severe autonomic involvement (EI, DI and SI respectively) based on the degree of abnormalities on tests of parasympathetic and sympathetic pathways.
RESULTS: Cardiac autonomic dysfunction was present in all (EI = 25.0%, DI = 41.7% and SI = 33.3%), parasympathetic dysfunction being an early feature. SI was most often present in SCA3 (100%), followed by those with SCA1 (66.7%), and SCA2 (20%) and none in IA.
CONCLUSIONS: Cardiac dysautonomia was common in both SCA and IA, although the severity was greater in SCA. Among SCAs, the severity was greatest in SCA3, followed by SCA2 and least in SCA1.

Entities:  

Mesh:

Year:  2009        PMID: 19178387     DOI: 10.1111/j.1600-0404.2008.01144.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

2.  Increased catabolic state in spinocerebellar ataxia type 1 patients.

Authors:  Anja Mähler; Jochen Steiniger; Matthias Endres; Friedemann Paul; Michael Boschmann; Sarah Doss
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

3.  Reduced cardiac 123I-metaiodobenzylguanidine uptake in patients with spinocerebellar ataxia type 2: a comparative study with Parkinson's disease.

Authors:  Anna De Rosa; Sabina Pappatà; Teresa Pellegrino; Maria Fulvia De Leva; Gennaro Maddaluno; Giovanni Fiumara; Raffaella Carotenuto; Mario Petretta; Alessandro Filla; Giuseppe De Michele; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-09       Impact factor: 9.236

4.  Clinical Features and Neuroimaging Findings of Neuropil Antibody-Positive Idiopathic Sporadic Ataxia of Unknown Etiology.

Authors:  Akira Takekoshi; Akio Kimura; Nobuaki Yoshikura; Isamu Yamakawa; Makoto Urushitani; Katsuya Nakamura; Kunihiro Yoshida; Takayoshi Shimohata
Journal:  Cerebellum       Date:  2022-09-03       Impact factor: 3.648

5.  Autonomic function testing in spinocerebellar ataxia type 2.

Authors:  Elisabetta Indelicato; Alessandra Fanciulli; Jean Pierre Ndayisaba; Wolfgang Nachbauer; Roberta Granata; Julia Wanschitz; Michaela Wagner; Elke R Gizewski; Werner Poewe; Gregor K Wenning; Sylvia Boesch
Journal:  Clin Auton Res       Date:  2018-02-12       Impact factor: 4.435

Review 6.  Nonmotor symptoms in spinocerebellar ataxias (SCAs).

Authors:  Adriana Moro; Mariana Moscovich; Marina Farah; Carlos Henrique F Camargo; Hélio A G Teive; Renato P Munhoz
Journal:  Cerebellum Ataxias       Date:  2019-08-27

7.  Body Mass Index Decline Is Related to Spinocerebellar Ataxia Disease Progression.

Authors:  Alhassane Diallo; Heike Jacobi; Tanja Schmitz-Hübsch; Arron Cook; Robyn Labrum; Alexandra Durr; Alexis Brice; Perrine Charles; Cecilia Marelli; Caterina Mariotti; Lorenzo Nanetti; Marta Panzeri; Maria Rakowicz; Anna Sobanska; Anna Sulek; Ludger Schöls; Holger Hengel; Bela Melegh; Alessandro Filla; Antonella Antenora; Jon Infante; José Berciano; Bart P van de Warrenburg; Dagmar Timmann; Sylvia Boesch; Massimo Pandolfo; Jörg B Schulz; Peter Bauer; Paola Giunti; Laszlo Baliko; Michael H Parkinson; Jun-Suk Kang; Thomas Klockgether; Sophie Tezenas du Montcel
Journal:  Mov Disord Clin Pract       Date:  2017-08-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.